Pear Therapeutics, Inc. Quarterly Return On Equity in % from Q4 2021 to Q4 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Pear Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q4 2022.
  • Pear Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2022 was -131 %, a 31.3% decline year-over-year.
  • Pear Therapeutics, Inc. annual Return On Equity for 2022 was -131 %, a 31.3% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q4 2022 -131 -31.1 -31.3% Oct 1, 2022 Dec 31, 2022
Q3 2022 -41.7 Jul 1, 2022 Sep 30, 2022
Q2 2022 -46.4 Apr 1, 2022 Jun 30, 2022
Q1 2022 -105 Jan 1, 2022 Mar 31, 2022
Q4 2021 -99.4 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.